Overview


According to FutureWise analysis, the market for Apheresis is expected to grow with a CAGR of 8.3% over the forecast period 2023-2031, and reach a market value of US$ 4.36 billion by 2031.

Apheresis is a medical practice that involves removing certain components of an individual's blood and returning the remaining blood components to the body. It's also known as "hemapheresis" or "apheresis." The procedure works by using a specialized machine called an apheresis machine, which separates the blood into its components (like plasma, red blood cells, white blood cells, and platelets) and collects or removes specific components as needed. The machine does this by spinning the blood in a centrifuge and using filters to separate the different components.

There are various types of apheresis procedures, including plasmapheresis, plateletpheresis, erythrocytapheresis, and leukapheresis. Plasmapheresis involves removing plasma from the blood. Plasma is the liquid substance of the blood that contains various proteins, including antibodies and clotting factors. Plasmapheresis is often used to treat conditions like autoimmune disorders and certain neurological diseases. Plateletpheresis is a procedure focused on removing platelets essential for blood clotting. Plateletpheresis is commonly performed to collect platelets for transfusion to patients with low platelet counts. Red blood cell exchange (Erythrocytapheresis) is a procedure that involves removing and replacing red blood cells. It is used in conditions like sickle cell disease and certain types of anemia. Leukapheresis targets white blood cells. It is used in certain conditions where there is an excess of specific types of white blood cells.

FutureWise Market Research has published a report that provides an insightful analysis apheresis market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts apheresis market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Terumo BCT, Inc.
  • Fresenius SeCo. KGaA
  • Haemonetics Corporation
  • Baxter International Inc.
  • Asahi Kasei Medical Co. Ltd. (A Subsidiary of Asahi Kasei Corporation)
  • B. Braun Melsungen AG
  • Cerus Corporation
  • Kaneka Corporation
  • Kawasumi Laboratories, Inc.
  • Nikkiso Co., Ltd.
  • Macopharma SA
  • Miltenyi Biotec
  • Otsuka Holdings Co., Ltd.
  • Medica Spa
  • Mallinckrodt Plc

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Apheresis Market:

  • In July 2022, Terumo Blood and Cell Technologies collaborated with Eliaz Therapeutics in developing and commercializing a novel therapeutic apheresis for the treatment of acute kidney injury (AKI).

 
The increasing prevalence of conditions like leukemia, multiple myeloma, and autoimmune disorders is a significant driver for the apheresis market. As these diseases become more standard, there is a growing need for advanced treatment options. Apheresis plays a critical role in managing and treating these conditions by releasing specific blood components, such as antibodies or diseased cells, effectively relieving symptoms and improving overall patient outcomes. This procedure is often an essential part of the therapeutic approach prescribed by healthcare providers. Its efficacy in targeting the underlying causes of these diseases positions apheresis as a vital and irreplaceable role in the modern medical sector. Additionally, the expanding applications of apheresis are a significant opportunity in the market. Ongoing research reveals promising uses in various medical fields, such as neurology, rheumatology, and transplantation medicine. In neurology, apheresis is used to treat conditions like Guillain-Barré syndrome and multiple sclerosis, where it shows potential in removing harmful antibodies and immune cells. In rheumatology, apheresis is a valuable tool for managing autoimmune disorders like rheumatoid arthritis and lupus by selectively filtering out disease-causing agents. Therefore, driving the market potential of apheresis technologies, extending new avenues for innovation and revenue generation in the healthcare industry. However, patients undergoing apheresis may experience adverse side effects, such as discomfort at the needle insertion site, transient light headedness, sweating, or a temporary drop in blood pressure. These effects may lead to patient discomfort and, in some cases, may require additional monitoring or intervention. This possibility of adverse reactions may hinder some individuals from choosing apheresis as their preferred treatment option. It could restrain its widespread adoption, particularly in cases where alternative therapies with fewer associated side effects are available.

By Product

  • Apheresis Disposables
  • Apheresis Devices
    • Centrifugal Apheresis Devices
    • Membrane Separators

By Procedure

  • Automated Blood Collection (Donor Apheresis)
  • Therapeutic Apheresis
    • Therapeutic Apheresis Disposables
      • Neurological Disorders
      • Blood Disorders
      • Renal Disorders
      • Autoimmune Disorders
      • Metabolic Disorders
      • Cardiovascular Disorders
    • Therapeutic Apheresis Devices

By Technology

  • Centrifugation
    • Continuous Flow Centrifugation
    • Intermittent Flow Centrifugation
  • Membrane Separation

By Application

  • Plasmapheresis
  • Plateletpheresis
  • Erythrocytapheresis
  • Leukapheresis
  • Photopheresis
  • Other Applications

By End User

  • Blood Collection Centers
  • Blood Component Providers
  • Hospitals and Transfusion Centers
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to factors like easier access to advanced blood collection technologies, the presence of well-developed healthcare infrastructure, an increase in demand for blood components, newly approved indications for apheresis treatment such as autoimmune hemolytic anemia, acute disseminated encephalomyelitis, and cardiac neonatal lupus in the US is anticipated to drive the growth of the market. Additionally, early adoption of novel apheresis systems, increasing product innovations and approvals, technological advancements in the development of new apheresis approaches, and an increase in reimbursement policies and funding for apheresis procedures further fuel the target market in the region during the forecast period. For example, in July 2021, Terumo Blood and Cell Technologies introduced a direct offering enabling physicians to conduct extracorporeal photopheresis (ECP) procedures at the patient's bedside. This was made possible by expanding the capabilities of their Spectra Optia system. With this enhancement, the UVA PIT System ECP can be performed using these devices as a functionally closed, online, multistep system with mononuclear cell collection (MNC) and continuous mononuclear cell collection (CMNC) protocols.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Apheresis Market By Product, By Procedure, By Technology, By Application, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Apheresis Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Apheresis Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Apheresis Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Application Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Application Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Apheresis Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Apheresis Disposables
        2. Apheresis Devices
         2.1. Centrifugal Apheresis Devices
         2.2. Membrane Separators

  • 8.   Apheresis Market, By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Automated Blood Collection (Donor Apheresis)
        2. Therapeutic Apheresis
         2.1. Therapeutic Apheresis Disposables
          2.1.1. Neurological Disorders
          2.1.2. Blood Disorders
          2.1.3. Renal Disorders
          2.1.4. Autoimmune Disorders
          2.1.5. Metabolic Disorders
          2.1.6. Cardiovascular Disorders
          2.1.7. Other Disorders
         2.2. Therapeutic Apheresis Devices

  • 9.   Apheresis Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Centrifugation
         1.1. Continuous Flow Centrifugation
         1.2. Intermittent Flow Centrifugation
        2. Membrane Separation

  • 10.   Apheresis Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Plasmapheresis
        2. Plateletpheresis
        3. Erythrocytapheresis
        4. Leukapheresis
        5. Photopheresis
        6. Other Applications

  • 11.   Apheresis Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Blood Collection Centers
        2. Blood Component Providers
        3. Hospitals and Transfusion Centers
        4. Other End Users

  • 12.   North America Apheresis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Apheresis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Apheresis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        16.3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Apheresis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Apheresis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Offered and Financial Layouts)
    •   1. Terumo BCT, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Fresenius SeCo. KGaA
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Haemonetics Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. PathoFinder BV
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Asahi Kasei Medical Co. Ltd. (A Subsidiary of Asahi Kasei Corporation)
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. B. Braun Melsungen AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Cerus Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Kaneka Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
         9. Kawasumi Laboratories, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Nikkiso Co., Ltd.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Macopharma SA
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Miltenyi Biotec
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Otsuka Holdings Co., Ltd.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Medica Spa
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Mallinckrodt Plc
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client

Related Market

Apheresis Systems Market

Read More

Apheresis Machines Market

Read More

Apheresis Equipment Market

Read More
Partner

Our Clients